TWi Biotechnology (ROCO:6610) Total Liabilities : NT$66.47 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is TWi Biotechnology Total Liabilities?

TWi Biotechnology's Total Liabilities for the quarter that ended in Dec. 2024 was NT$66.47 Mil.

TWi Biotechnology's quarterly Total Liabilities increased from Dec. 2023 (NT$55.81 Mil) to Jun. 2024 (NT$56.23 Mil) and increased from Jun. 2024 (NT$56.23 Mil) to Dec. 2024 (NT$66.47 Mil).

TWi Biotechnology's annual Total Liabilities increased from Dec. 2022 (NT$28.39 Mil) to Dec. 2023 (NT$55.81 Mil) and increased from Dec. 2023 (NT$55.81 Mil) to Dec. 2024 (NT$66.47 Mil).

TWi Biotechnology Total Liabilities Historical Data

The historical data trend for TWi Biotechnology's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TWi Biotechnology Total Liabilities Chart

TWi Biotechnology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

92.93

32.24

28.39

55.81

66.47

TWi Biotechnology Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Liabilities	Get a 7-Day Free Trial															28.39	25.85	55.81	56.23	66.47

TWi Biotechnology Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

TWi Biotechnology's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	60.769	+	(2.946	+	2.759
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	66.47

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	242.321	-	175.847
	=	66.47

TWi Biotechnology's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	60.769	+	(2.946	+	2.759
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	66.47

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	242.321	-	175.847
	=	66.47

TWi Biotechnology Total Liabilities Related Terms

Thank you for viewing the detailed overview of TWi Biotechnology's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

TWi Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TWi Biotechnology Inc (ROCO:6610) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 221, Kang Chien Road, 8th Floor, Number 41, Neihu District, Taipei, TWN, 11494

Website

https://www.twibiotech.com

TWi Biotechnology Inc is a clinical-stage biopharmaceutical company based in Taiwan. It is engaged in the development of new drugs for unmet medical needs, particularly in the diseases associated with innate immunity. The pipeline products of the company comprise AC-201, AC-203, and AC-701.

TWi Biotechnology Headlines

No Headlines